Term ends Feb 26, 2040 · High confidence
20-year base term ends Aug 9, 2039
Held by Akeso Biopharma, Inc.
Filed Sep 15, 2020 as application 16/980,853 · Granted May 30, 2023
Base term plus 201 days of patent term adjustment (USPTO delay)
Today
2019
2040
Clock starts
Aug 9, 2019
Aug 9, 2019
Term ends
Feb 26, 2040
Feb 26, 2040
Granted
May 30, 2023
May 30, 2023
base term
patent term adjustment
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
201
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
2
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 201 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 9, 2019, when application PCT/CN2019/099989, the earliest non-provisional in its chain, was filed (this one was filed Sep 15, 2020) | Aug 9, 2039 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +201 days, USPTO patent term adjustment record | Feb 26, 2040 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Feb 26, 2040 | High confidence |
Partial family
| Application PCT/CN2019/099989 | PCT application no patent term | no patent term |
| US 11,661,454 | this patent Feb 2040 | Feb 2040 |
Partial: 1 of the 2 has no file history here, so its row comes from the patent's own record or names the application alone. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 22, 2020 Reel 53851, frame 581 | Wang, Guoxing; Cheng, Liansheng; Hu, Siyi; Yuan, Hong; Wu, Ting; Fan, Li | Anhui Biox Vision Biological Technology Co., Ltd. | Assignment of Assignor's Interest |
| Jun 3, 2025 Reel 71293, frame 143 | Anhui Biox Vision Biological Technology Co., Ltd. | Akeso Biopharma, Inc. | Assignment of Assignor's Interest |
| Jun 13, 2025 Reel 71550, frame 458 | Anhui Biox Vision Biological Technology Co., Ltd. | Akeso Biopharma, Inc. | Corrective Assignment to Correct the Assignee Address Previously Recorded on Reel 71293 Frame 143. Assignor(S) Hereby Confirms the Assignment. |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2040
Term ends Feb 26, 2040. Maintenance fees still fall due before then
Note
The 201 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
1
later US patent cites this one
That is below the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.